163 related articles for article (PubMed ID: 24038777)
1. Systematic analysis of funding awarded for antimicrobial resistance research to institutions in the UK, 1997-2010.
Head MG; Fitchett JR; Cooke MK; Wurie FB; Atun R; Hayward AC; Holmes A; Johnson AP; Woodford N
J Antimicrob Chemother; 2014 Feb; 69(2):548-54. PubMed ID: 24038777
[TBL] [Abstract][Full Text] [Related]
2. Systematic analysis of funding awarded for mycology research to institutions in the UK, 1997-2010.
Head MG; Fitchett JR; Atun R; May RC
BMJ Open; 2014 Jan; 4(1):e004129. PubMed ID: 24413353
[TBL] [Abstract][Full Text] [Related]
3. Funding healthcare-associated infection research: a systematic analysis of UK research investments, 1997-2010.
Head MG; Fitchett JR; Holmes AH; Atun R
J Hosp Infect; 2014 Jun; 87(2):84-91. PubMed ID: 24815767
[TBL] [Abstract][Full Text] [Related]
4. Research investments for UK infectious disease research 1997-2013: A systematic analysis of awards to UK institutions alongside national burden of disease.
Head MG; Brown RJ; Clarke SC
J Infect; 2018 Jan; 76(1):11-19. PubMed ID: 29061335
[TBL] [Abstract][Full Text] [Related]
5. Comparing research investment to United Kingdom institutions and published outputs for tuberculosis, HIV and malaria: a systematic analysis across 1997-2013.
Head MG; Fitchett JR; Derrick G; Wurie FB; Meldrum J; Kumari N; Beattie B; Counts CJ; Atun R
Health Res Policy Syst; 2015 Nov; 13():63. PubMed ID: 26537547
[TBL] [Abstract][Full Text] [Related]
6. UK investments in global infectious disease research 1997-2010: a case study.
Head MG; Fitchett JR; Cooke MK; Wurie FB; Hayward AC; Atun R
Lancet Infect Dis; 2013 Jan; 13(1):55-64. PubMed ID: 23140942
[TBL] [Abstract][Full Text] [Related]
7. Investments in cancer research awarded to UK institutions and the global burden of cancer 2000-2013: a systematic analysis.
Maruthappu M; Head MG; Zhou CD; Gilbert BJ; El-Harasis MA; Raine R; Fitchett JR; Atun R
BMJ Open; 2017 Apr; 7(4):e013936. PubMed ID: 28428185
[TBL] [Abstract][Full Text] [Related]
8. Investments in respiratory infectious disease research 1997-2010: a systematic analysis of UK funding.
Head MG; Fitchett JR; Cooke MK; Wurie FB; Hayward AC; Lipman MC; Atun R
BMJ Open; 2014 Mar; 4(3):e004600. PubMed ID: 24670431
[TBL] [Abstract][Full Text] [Related]
9. UK and European Union public and charitable funding from 2008 to 2013 for bacteriology and antibiotic research in the UK: an observational study.
Bragginton EC; Piddock LJ
Lancet Infect Dis; 2014 Sep; 14(9):857-68. PubMed ID: 25065509
[TBL] [Abstract][Full Text] [Related]
10. Public funding for research on antibacterial resistance in the JPIAMR countries, the European Commission, and related European Union agencies: a systematic observational analysis.
Kelly R; Zoubiane G; Walsh D; Ward R; Goossens H
Lancet Infect Dis; 2016 Apr; 16(4):431-40. PubMed ID: 26708524
[TBL] [Abstract][Full Text] [Related]
11. Funding infectious disease research: a systematic analysis of UK research investments by funders 1997-2010.
Fitchett JR; Head MG; Cooke MK; Wurie FB; Atun R
PLoS One; 2014; 9(8):e105722. PubMed ID: 25162631
[TBL] [Abstract][Full Text] [Related]
12. Systematic analysis of funding awarded for viral hepatitis-related research to institutions in the United Kingdom, 1997-2010.
Head MG; Fitchett JR; Cooke GS; Foster GR; Atun R
J Viral Hepat; 2015 Mar; 22(3):230-7. PubMed ID: 25146854
[TBL] [Abstract][Full Text] [Related]
13. Differences in research funding for women scientists: a systematic comparison of UK investments in global infectious disease research during 1997-2010.
Head MG; Fitchett JR; Cooke MK; Wurie FB; Atun R
BMJ Open; 2013 Dec; 3(12):e003362. PubMed ID: 24327360
[TBL] [Abstract][Full Text] [Related]
14. Mapping pneumonia research: A systematic analysis of UK investments and published outputs 1997-2013.
Head MG; Fitchett JR; Newell ML; Scott JA; Harris JN; Clarke SC; Atun R
EBioMedicine; 2015 Sep; 2(9):1193-9. PubMed ID: 26501117
[TBL] [Abstract][Full Text] [Related]
15. Systematic analysis of funding awarded to institutions in the United Kingdom for infectious disease research, 1997-2010.
Head MG; Fitchett JR; Moore DA; Atun R
JRSM Open; 2015 Mar; 6(3):2054270415577056. PubMed ID: 25893108
[TBL] [Abstract][Full Text] [Related]
16. Infectious disease research investments: systematic analysis of immunology and vaccine research funding in the UK.
Fitchett JR; Head MG; Atun R
Vaccine; 2013 Dec; 31(50):5930-3. PubMed ID: 24176489
[TBL] [Abstract][Full Text] [Related]
17. Mapping Investments and Published Outputs in Norovirus Research: A Systematic Analysis of Research Funded in the United States and United Kingdom During 1997-2013.
Head MG; Fitchett JR; Lichtman AB; Soyode DT; Harris JN; Atun R
J Infect Dis; 2016 Feb; 213 Suppl 1(Suppl 1):S3-7. PubMed ID: 26744430
[TBL] [Abstract][Full Text] [Related]
18. A systematic analysis of UK cancer research funding by gender of primary investigator.
Zhou CD; Head MG; Marshall DC; Gilbert BJ; El-Harasis MA; Raine R; O'Connor H; Atun R; Maruthappu M
BMJ Open; 2018 Apr; 8(4):e018625. PubMed ID: 29712689
[TBL] [Abstract][Full Text] [Related]
19. Investments in sexually transmitted infection research, 1997-2013: a systematic analysis of funding awarded to UK institutions.
Head MG; Fitchett JR; Cassell JA; Atun R
J Glob Health; 2015 Dec; 5(2):020405. PubMed ID: 26322229
[TBL] [Abstract][Full Text] [Related]
20. Research Investments in Global Health: A Systematic Analysis of UK Infectious Disease Research Funding and Global Health Metrics, 1997-2013.
Head MG; Fitchett JR; Nageshwaran V; Kumari N; Hayward A; Atun R
EBioMedicine; 2016 Jan; 3():180-190. PubMed ID: 26870829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
